Editorial: Metabolic disorders as risk factors for osteoarthritis and targeted therapies for this pathology
Saved in:
Main Authors: | Giuseppe Lisco, Hee Geun Jo, Graziana Colaianni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1540942/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stem cells for osteoarthritis: Recent advances in related cell therapy
by: Jianjing Lin, et al.
Published: (2025-01-01) -
Combination of rapamycin and adipose-derived mesenchymal stromal cells enhances therapeutic potential for osteoarthritis
by: Damien Veret, et al.
Published: (2025-01-01) -
Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis
by: Zhang Q, et al.
Published: (2025-01-01) -
Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
by: I Gusti Ngurah Wien Aryana, et al.
Published: (2023-10-01) -
Research Progress on Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis
by: GONG Jin, et al.
Published: (2025-01-01)